Epothilones and the next generation of phase III trials for prostate cancer

BJU Int. 2005 Aug;96(3):296-302. doi: 10.1111/j.1464-410X.2005.05618.x.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Clinical Trials, Phase II as Topic
  • Clinical Trials, Phase III as Topic*
  • Epothilones / administration & dosage
  • Epothilones / therapeutic use*
  • Estramustine / administration & dosage
  • Humans
  • Male
  • Prostatic Neoplasms / drug therapy*
  • Randomized Controlled Trials as Topic
  • Taxoids / therapeutic use

Substances

  • BMS 310705
  • Epothilones
  • Taxoids
  • Estramustine
  • ixabepilone
  • epothilone B